Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Center Rock acquires Merit Distribution from Centre Lane Partners Center Rock acquisition of Merit Distribution : Michigan-based private equity firm Center Rock Capital Partners has acquired The… byPallavi MadhirajuApril 20, 2019
